Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed software/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a backend/site revision without changing the study record content.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 (v3.4.3 removed).SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page metadata.SummaryDifference0.1%

- Check74 days agoChange DetectedMinor site maintenance updates were applied: Revision v3.4.2 added and the earlier notices (including Revision v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice about funding status and operating status was added, and the release notes show Revision: v3.4.1. These updates do not alter the study content or its reported information.SummaryDifference0.4%

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.